Organovo Holdings, Inc.(NASDAQ : ONVO)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Loading ONVO News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.03%||67.51||1.0%||$573.84m|
|REGN||Regeneron Pharmaceuticals, Inc.||2.19%||373.00||2.1%||$318.70m|
|KITE||Kite Pharma, Inc.||3.14%||76.84||18.8%||$216.10m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.83%||119.26||1.6%||$202.32m|
|ESPR||Esperion Therapeutics, Inc.||-3.61%||38.94||18.7%||$166.57m|
|AUPH||Aurinia Pharmaceuticals Inc.||-4.41%||8.02||6.3%||$143.97m|
|CLVS||Clovis Oncology, Inc.||2.61%||70.32||17.5%||$141.44m|
|VRTX||Vertex Pharmaceuticals Incorporated||1.04%||89.98||2.2%||$134.68m|
Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA.